Robert E Schmidt Selected Research

Neuroaxonal Dystrophies (Neuroaxonal Dystrophy, Late Infantile)

2/2008	Disrupted membrane homeostasis and accumulation of ubiquitinated proteins in a mouse model of infantile neuroaxonal dystrophy caused by PLA2G6 mutations.
10/2006	Sympathetic neuroaxonal dystrophy in the aged rat pineal gland.
4/2005	A potent sorbitol dehydrogenase inhibitor exacerbates sympathetic autonomic neuropathy in rats with streptozotocin-induced diabetes.
11/2004	Ganglion-specific patterns of diabetes-modulated gene expression are established in prevertebral and paravertebral sympathetic ganglia prior to the development of neuroaxonal dystrophy.
5/2004	Experimental rat models of types 1 and 2 diabetes differ in sympathetic neuroaxonal dystrophy.
7/2003	Analysis of the Zucker Diabetic Fatty (ZDF) type 2 diabetic rat model suggests a neurotrophic role for insulin/IGF-I in diabetic autonomic neuropathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert E Schmidt Research Topics

Disease

9	Neoplasms (Cancer) 11/2022 - 08/2003
7	Diabetic Neuropathies (Diabetic Neuropathy) 12/2011 - 01/2002
6	Necrosis 01/2017 - 03/2006
6	Neuroaxonal Dystrophies (Neuroaxonal Dystrophy, Late Infantile) 02/2008 - 07/2003
4	Cognitive Dysfunction 03/2018 - 12/2009
4	Inflammation (Inflammations) 01/2017 - 03/2008
4	Hyperglycemia 05/2004 - 01/2002
3	Hemorrhage 11/2022 - 05/2014
3	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 01/2018
3	Leukoencephalopathies 11/2018 - 03/2006
3	Virus Diseases (Viral Diseases) 01/2016 - 11/2005
3	Atrophy 11/2015 - 07/2010
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 04/2005 - 11/2003
3	Type 2 Diabetes Mellitus (MODY) 04/2005 - 11/2003
2	Infections 01/2019 - 01/2012
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2019 - 07/2011
2	Hypoxia (Hypoxemia) 12/2018 - 01/2017
2	Neoplasm Metastasis (Metastasis) 11/2016 - 01/2013
2	Neurofibrosarcoma (MPNST) 10/2016 - 08/2003
2	Pain (Aches) 01/2016 - 06/2012
2	Multiple Sclerosis 05/2015 - 11/2008
2	Telangiectasis (Telangiectasia) 07/2014 - 05/2014
2	Dementia (Dementias) 02/2014 - 02/2013
2	Parkinson Disease (Parkinson's Disease) 02/2014 - 02/2006
2	Melanoma (Melanoma, Malignant) 09/2013 - 01/2013
2	Body Weight (Weight, Body) 12/2011 - 05/2004
2	Starvation 11/2010 - 10/2009
2	Weight Gain 11/2010 - 09/2010
2	Hyperplasia 06/2010 - 08/2003
1	Giant Cell Tumors (Giant Cell Tumor) 11/2022
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2022
1	Tauopathies 01/2021
1	Demyelinating Diseases (Demyelinating Disease) 01/2020
1	White Dot Syndromes 06/2019
1	Acute Retinal Necrosis Syndrome 06/2019
1	Focal Cortical Dysplasia 01/2019
1	Hematologic Neoplasms (Hematological Malignancy) 01/2019
1	Thalassemia 01/2019
1	Progressive Multifocal Leukoencephalopathy 01/2019
1	Epilepsy (Aura) 01/2019
1	Intellectual Disability (Idiocy) 01/2019
1	Gliosis 12/2018
1	Frontotemporal Dementia (Semantic Dementia) 12/2018
1	Ischemic Stroke 11/2018
1	Autoimmune Diseases of the Nervous System 03/2018
1	Anaplasia 12/2017
1	Periventricular Nodular Heterotopia 05/2017
1	Neuronal Ceroid-Lipofuscinoses (Neuronal Ceroid Lipofuscinosis) 01/2017
1	Immune Reconstitution Inflammatory Syndrome 01/2017
1	Ataxia (Dyssynergia) 01/2017
1	Lymphopenia (Lymphocytopenia) 01/2017

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2007
5	NAD (NADH)IBA 10/2006 - 07/2003
4	Antiviral Agents (Antivirals)IBA 06/2019 - 11/2005
4	Insulin (Novolin)FDA Link 12/2011 - 07/2003
4	Streptozocin (Streptozotocin)FDA Link 04/2005 - 07/2003
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2015
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 05/2014
3	Methylprednisolone FDA LinkGeneric 01/2017 - 09/2008
3	Insulin-Like Growth Factor I (IGF-1)IBA 01/2008 - 07/2003
2	Transcription Factors (Transcription Factor)IBA 12/2018 - 02/2005
2	Formaldehyde (Formol)FDA Link 11/2018 - 06/2005
2	Retinaldehyde (Retinal)IBA 11/2018 - 11/2016
2	SteroidsIBA 01/2017 - 09/2008
2	Intravenous Immunoglobulins (IVIG)FDA Link 01/2017 - 01/2016
2	AntibodiesIBA 01/2017 - 05/2014
2	Complement System Proteins (Complement)IBA 01/2016 - 07/2010
2	Bevacizumab (Avastin)FDA Link 11/2015 - 05/2014
2	Blood Glucose (Blood Sugar)IBA 12/2011 - 09/2010
2	Glucose (Dextrose)FDA LinkGeneric 11/2010 - 07/2003
2	Calcium-Independent Phospholipases A2IBA 12/2009 - 02/2008
2	ElementsIBA 11/2003 - 07/2003
1	Capsules (Microcapsules)IBA 11/2022
1	Biological ProductsIBA 11/2022
1	Keratins (Keratin)IBA 11/2022
1	HemosiderinIBA 11/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	LDL Receptors (LDL Receptor)IBA 01/2021
1	Apolipoproteins E (ApoE)IBA 01/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2019
1	Immune Checkpoint InhibitorsIBA 01/2019
1	K Cl- CotransportersIBA 01/2019
1	miltefosine (Impavido)IBA 01/2019
1	Potassium Chloride FDA LinkGeneric 01/2019
1	NivolumabIBA 01/2019
1	X-linked Nuclear ProteinIBA 01/2019
1	Glial Fibrillary Acidic ProteinIBA 12/2018
1	ParaffinIBA 11/2018
1	three prime repair exonuclease 1IBA 11/2018
1	AutoantibodiesIBA 03/2018
1	IsotopesIBA 01/2018
1	Amyloid (Amyloid Fibrils)IBA 01/2018
1	Cadherins (E-Cadherin)IBA 05/2017
1	Mirtazapine (Rexer)FDA LinkGeneric 01/2017
1	Interleukin-7 (Interleukin 7)IBA 01/2017
1	Mefloquine (Lariam)FDA LinkGeneric 01/2017
1	EnzymesIBA 01/2017
1	palmitoyl-protein thioesteraseIBA 01/2017

Therapy/Procedure

10	Therapeutics 06/2019 - 03/2006
2	Drug Therapy (Chemotherapy) 12/2017 - 03/2006